Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017 (2017), Article ID 8587260, 16 pages
https://doi.org/10.1155/2017/8587260
Research Article

Xanthone and Flavone Derivatives as Dual Agents with Acetylcholinesterase Inhibition and Antioxidant Activity as Potential Anti-Alzheimer Agents

1Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal
2Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
3Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Edifício do Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos s/n, 4050-208 Matosinhos, Portugal

Correspondence should be addressed to Honorina Cidade and Madalena Pinto

Received 14 November 2016; Revised 9 February 2017; Accepted 13 February 2017; Published 26 March 2017

Academic Editor: Sevgi Kolaylı

Copyright © 2017 Inês Cruz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Cavalli, M. L. Bolognesi, A. Mìnarini et al., “Multi-target-directed ligands to combat neurodegenerative diseases,” Journal of Medicinal Chemistry, vol. 51, no. 3, pp. 347–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Guzior, A. Więckowska, D. Panek, and B. Malawska, “Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease,” Current Medicinal Chemistry, vol. 22, no. 3, pp. 373–404, 2015. View at Google Scholar · View at Scopus
  3. J. D. Grill and J. L. Cummings, “Current therapeutic targets for the treatment of Alzheimer's disease,” Expert Review of Neurotherapeutics, vol. 10, no. 5, pp. 711–728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Fassbender, C. Masters, and K. Beyreuther, “Alzheimer's disease: molecular concepts and therapeutic targets,” Naturwissenschaften, vol. 88, no. 6, pp. 261–267, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kumar, S. A. Khan, L. Bhakuni et al., “Global burden of Alzheimer's disease and promising potential of herbal medicines,” Indian Journal of Drugs, vol. 1, no. 2, pp. 55–62, 2013. View at Google Scholar
  6. H.-Y. Zhang, “One-compound-multiple-targets strategy to combat Alzheimer's disease,” FEBS Letters, vol. 579, no. 24, pp. 5260–5264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. S. T. Dias and C. Viegas Jr., “Multi-target directed drugs: a modern approach for design of new drugs for the treatment of Alzheimer's disease,” Current Neuropharmacology, vol. 12, no. 3, pp. 239–255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. S. Negi, V. K. Bisht, P. Singh, M. S. M. Rawat, and G. P. Joshi, “Naturally occurring xanthones: chemistry and biology,” Journal of Applied Chemistry, vol. 2013, Article ID 621459, 9 pages, 2013. View at Publisher · View at Google Scholar
  9. M. S. J. Nascimento, M. E. Sousa, and M. M. M. Pinto, “Xanthone derivatives: new insights in biological activities,” Current Medicinal Chemistry, vol. 12, no. 21, pp. 2517–2538, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Martens and A. Mithöfer, “Flavones and flavone synthases,” Phytochemistry, vol. 66, no. 20, pp. 2399–2407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Singh, M. Kaur, and O. Silakari, “Flavones: an important scaffold for medicinal chemistry,” European Journal of Medicinal Chemistry, vol. 84, pp. 206–239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Jia, S. Li, X. Hu, G. Zhu, and W. Chen, “Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi,” AAPS PharmSciTech, vol. 16, no. 4, pp. 742–758, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. C. V. Simoben, A. Ibezim, F. Ntie-Kang, J. N. Nwodo, and L. L. Lifongo, “Exploring cancer therapeutics with natural products from African medicinal plants, part I: xanthones, quinones, steroids, coumarins, phenolics and other classes of compounds,” Anti-Cancer Agents in Medicinal Chemistry, vol. 15, no. 9, pp. 1092–1111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Verma and R. Pratap, “The biological potential of flavones,” Natural Product Reports, vol. 27, no. 11, pp. 1571–1593, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. H. R. El-Seedi, M. A. El-Barbary, D. M. H. El-Ghorab et al., “Recent insights into the biosynthesis and biological activities of natural xanthones,” Current Medicinal Chemistry, vol. 17, no. 9, pp. 854–901, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Kingston, G. Cragg, and D. Newman, Anticancer Agents from Natural Products, CRC Press, 2005. View at Publisher · View at Google Scholar
  17. J. Qin, W. Lan, Z. Liu, J. Huang, H. Tang, and H. Wang, “Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents,” Chemistry Central Journal, vol. 7, no. 1, article 78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. K. S. Bhullar and H. P. V. Rupasinghe, “Polyphenols: multipotent therapeutic agents in neurodegenerative diseases,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 891748, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. S. Panda, M. Chand, R. Sakhuja, and S. C. Jain, “Xanthones as potential antioxidants,” Current Medicinal Chemistry, vol. 20, no. 36, pp. 4481–4507, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H.-Y. Zhang, D.-P. Yang, and G.-Y. Tang, “Multipotent antioxidants: from screening to design,” Drug Discovery Today, vol. 11, no. 15-16, pp. 749–754, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-F. Ji and H.-Y. Zhang, “Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer's disease,” Journal of Molecular Structure: THEOCHEM, vol. 767, no. 1-3, pp. 3–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. I. Cruz, Xanthone and flavone derivatives as potential dual agents for Alzheimer's disease [M.S. thesis], Universidade do Porto, Porto, Portugal, 2015, https://repositorio-aberto.up.pt/bitstream/10216/85633/2/36426.pdf.
  23. M.-H. Lee, R.-D. Lin, L.-Y. Shen, L.-L. Yang, K.-Y. Yen, and W.-C. Hou, “Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don,” Journal of Agricultural and Food Chemistry, vol. 49, no. 11, pp. 5551–5555, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Brühlmann, A. Marston, K. Hostettmann, P.-A. Carrupt, and B. Testa, “Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors,” Chemistry and Biodiversity, vol. 1, no. 6, pp. 819–829, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Urbain, A. Marston, E. F. Queiroz, K. Ndjoko, and K. Hostettmann, “Xanthones from Gentiana campestris as new acetylcholinesterase inhibitors,” Planta Medica, vol. 70, no. 10, pp. 1011–1014, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Chimenti, R. Fioravanti, A. Bolasco et al., “A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors,” Bioorganic and Medicinal Chemistry, vol. 18, no. 3, pp. 1273–1279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Uriarte-Pueyo and M. I. Calvo, “Flavonoids as acetylcholinesterase inhibitors,” Current Medicinal Chemistry, vol. 18, no. 34, pp. 5289–5302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Rizzo, A. Cavalli, L. Ceccarini et al., “Structure-activity relationships and binding mode in the human acetylcholinesterase active site of Pseudo-irreversible inhibitors related to xanthostigmine,” ChemMedChem, vol. 4, no. 4, pp. 670–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Wang, Z. Xia, J.-R. Xu et al., “α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation,” Neuropharmacology, vol. 62, no. 2, pp. 871–881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. R. C. Y. Choi, J. T. T. Zhu, A. W. Y. Yung et al., “Synergistic action of flavonoids, baicalein, and daidzein in estrogenic and neuroprotective effects: a development of potential health products and therapeutic drugs against Alzheimer's disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 635694, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Jiménez-Aliaga, P. Bermejo-Bescós, J. Benedí, and S. Martín-Aragón, “Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells,” Life Sciences, vol. 89, no. 25-26, pp. 939–945, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Uvarani, K. Chandraprakash, M. Sankaran, A. Ata, and P. S. Mohan, “Antioxidant and structure-activity relationships of five tetraoxygenated xanthones from Swertia minor (Griscb.) Knobl,” Natural Product Research, vol. 26, no. 13, pp. 1265–1270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Grazul and E. Budzisz, “Biological activity of metal ions complexes of chromones, coumarins and flavones,” Coordination Chemistry Reviews, vol. 253, no. 21-22, pp. 2588–2598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Hanasaki, S. Ogawa, and S. Fukui, “The correlation between active oxygens scavenging and antioxidative effects of flavonoids,” Free Radical Biology and Medicine, vol. 16, no. 6, pp. 845–850, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Magnani, E. M. Gaydou, and J. C. Hubaud, “Spectrophotometric measurement of antioxidant properties of flavones and flavonols against superoxide anion,” Analytica Chimica Acta, vol. 411, no. 1-2, pp. 209–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. C. M. M. Santos, M. Freitas, D. Ribeiro et al., “2,3-Diarylxanthones as strong scavengers of reactive oxygen and nitrogen species: a structure–activity relationship study,” Bioorganic and Medicinal Chemistry, vol. 18, no. 18, pp. 6776–6784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Cidade, V. Rocha, A. Palmeira et al., “In silico and in vitro antioxidant and cytotoxicity evaluation of oxygenated xanthone derivatives,” Arabian Journal of Chemistry, 2017. View at Publisher · View at Google Scholar
  38. E. Costa, E. Sousa, N. Nazareth, M. S. J. Nascimento, and M. M. M. Pinto, “Synthesis of xanthones and benzophenones as inhibitors of tumor cell growth,” Letters in Drug Design & Discovery, vol. 7, no. 7, pp. 487–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Fernandes, A. M. S. Silva, J. A. S. Cavaleiro, F. M. Silva, M. F. M. Borges, and M. M. M. Pinto, “1H and Spectroscopy of Mono-, Di-, Tri- 13C NMR and Tetrasubstituted Xanthones,” Magnetic Ressonance in Chemistry, vol. 36, pp. 305–309, 1998. View at Google Scholar
  40. L. R. Fukumoto and G. Mazza, “Assessing antioxidant and prooxidant activities of phenolic compounds,” Journal of Agricultural and Food Chemistry, vol. 48, no. 8, pp. 3597–3604, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. W. Brand-Williams, M. E. Cuvelier, and C. Berset, “Use of a free radical method to evaluate antioxidant activity,” LWT—Food Science and Technology, vol. 28, no. 1, pp. 25–30, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. A. P. Vale, H. Cidade, M. Pinto, and M. B. P. P. Oliveira, “Effect of sprouting and light cycle on antioxidant activity of Brassica oleracea varieties,” Food Chemistry, vol. 165, pp. 379–387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. T. C. P. Dinis, V. M. C. Madeira, and L. M. Almeida, “Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers,” Archives of Biochemistry and Biophysics, vol. 315, no. 1, pp. 161–169, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. J. E. Brown, H. Khodr, R. C. Hider, and C. A. Rice-Evans, “Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties,” Biochemical Journal, vol. 330, no. 3, pp. 1173–1178, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. M. C. da Silva, H. Cidade, E. Sousa, and M. Pinto, “Searching for small molecules with antioxidant and anticoagulant properties to fight thrombosis,” American Journal of Pharmaceutical Sciences and Nanotechnology, vol. 1, no. 1, pp. 43–50, 2014. View at Google Scholar
  46. G. L. Ellman, K. D. Courtney, V. Andres Jr., and R. M. Featherstone, “A new and rapid colorimetric determination of acetylcholinesterase activity,” Biochemical Pharmacology, vol. 7, no. 2, pp. 88–95, 1961. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Cheung, M. J. Rudolph, F. Burshteyn et al., “Structures of human acetylcholinesterase in complex with pharmacologically important ligands,” Journal of Medicinal Chemistry, vol. 55, no. 22, pp. 10282–10286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. J. L. Sussman, D. Lin, J. Jiang et al., “Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules,” Acta Crystallographica Section D: Biological Crystallography, vol. 54, no. 6, part 1, pp. 1078–1084, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Froimowitz, “HyperChem: a software package for computational chemistry and molecular modeling,” BioTechniques, vol. 14, no. 6, pp. 1010–1013, 1993. View at Google Scholar · View at Scopus
  50. O. Trott and A. J. Olson, “Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading,” Journal of Computational Chemistry, vol. 31, no. 2, pp. 455–461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Seeliger and B. L. de Groot, “Ligand docking and binding site analysis with PyMOL and Autodock/Vina,” Journal of Computer-Aided Molecular Design, vol. 24, no. 5, pp. 417–422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Vilar, G. Cozza, and S. Moro, “Medicinal chemistry and the Molecular Operating Environment (MOE): application of QSAR and molecular docking to drug discovery,” Current Topics in Medicinal Chemistry, vol. 8, no. 18, pp. 1555–1572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. P. E. Eaton, G. R. Carlson, and J. T. Lee, “Phosphorus pentoxide-methanesulfonic acid. Convenient alternative to polyphosphoric acid,” Journal of Organic Chemistry, vol. 38, no. 23, pp. 4071–4073, 1973. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Fonteneau, P. Martin, M. Mondon, H. Ficheux, and J.-P. Gesson, “Synthesis of quinone and xanthone analogs of rhein,” Tetrahedron, vol. 57, no. 44, pp. 9131–9135, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. S. v. Kostanecki and B. Nessler, “Synthesen von Oxyxanthonen,” Berichte der deutschen chemischen Gesellschaft, vol. 24, no. 1, pp. 1894–1897, 1891. View at Publisher · View at Google Scholar · View at Scopus
  56. C. M. G. Azevedo, C. M. M. Afonso, and M. M. M. Pinto, “Routes to xanthones: an update on the synthetic approaches,” Current Organic Chemistry, vol. 16, no. 23, pp. 2818–2867, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Zhang, J. Ma, Y. Bao et al., “Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: synthesis, SAR analysis, and biological activity,” Bioorganic and Medicinal Chemistry, vol. 16, no. 15, pp. 7127–7132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Altamura and M. U. Muckenthaler, “Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis,” Journal of Alzheimer's Disease, vol. 16, no. 4, pp. 879–895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Chauhan and A. Chauhan, “Oxidative stress in Alzheimer's disease,” Pathophysiology, vol. 13, no. 3, pp. 195–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Gella and N. Durany, “Oxidative stress in Alzheimer disease,” Cell Adhesion and Migration, vol. 3, no. 1, pp. 88–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. B. Colovic, D. Z. Krstic, T. D. Lazarevic-Pasti, A. M. Bondzic, and V. M. Vasic, “Acetylcholinesterase inhibitors: pharmacology and toxicology,” Current Neuropharmacology, vol. 11, no. 3, pp. 315–335, 2013. View at Publisher · View at Google Scholar
  62. S.-H. Lu, J. W. Wu, H.-L. Liu et al., “The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies,” Journal of Biomedical Science, vol. 18, no. 1, article 8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Dvir, I. Silman, M. Harel, T. L. Rosenberry, and J. L. Sussman, “Acetylcholinesterase: from 3D structure to function,” Chemico-Biological Interactions, vol. 187, no. 1–3, pp. 10–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Barbosa, R. T. Lima, D. Sousa et al., “Screening a small library of xanthones for antitumor activity and identification of a hit compound which induces apoptosis,” Molecules, vol. 21, no. 1, p. 81, 2016. View at Publisher · View at Google Scholar